v3.26.1
Fair Value Measurements and Financial Instruments - Narrative (Details)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Gain (losses) on equity securities still held $ 70.3 $ (36.2) $ 43.1 $ (82.0)  
Financial Royalty Assets, Current          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Financial royalty asset, percentage of non-controlling interest     9.00%   7.00%
Financial Royalty Assets, Non-current          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Financial royalty asset, percentage of non-controlling interest     6.00%   7.00%
Level 3 | Estimate of Fair Value Measurement          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Financing receivables, fair value disclosure, current 900.0   $ 900.0   $ 900.0
Financing receivables, fair value disclosure, non-current $ 23,700.0   $ 23,700.0   $ 23,400.0
Level 3 | Measurement Input, Option Volatility          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Measurement input 0.375   0.375   0.425
Level 3 | Measurement Input, Discount Rate | Cytokinetics          
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]          
Measurement input 0.142   0.142   0.109